Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday forecast better-than-expected sequential growth of 22 percent in revenue this quarter after the world’s top contract chipmaker posted a quarterly net profit that beat analysts’ expectations, fueled by resilient smartphone demand.
Revenue is expected to swell to between NT$180 billion and NT$183 billion (US$5.97 billion and 6.07 billion) in the current quarter, compared with NT$148.22 billion last quarter, with the strongest growth from the communications segment, TSMC chief financial executive officer Lora Ho (何麗梅) said.
The “unseasonably strong” growth cited by TSMC exceeds the 15 percent sequential expansion estimated by Credit Suisse analyst Randy Abrams. He forecast that TSMC’s revenue would expand to NT$169 billion this quarter.
Photo: Reuters / Pichi Chuang
Abrams retained his “outperform” rating on TSMC with a target price of NT$130.
“Since mid-January, we started to see strong orders across all segments. We now adjust our demand outlook,” TSMC co-CEO Mark Liu (劉德音) said. “First, the demand for smartphones appears healthier than we expect. Second, our 28-nanometer technology’s performance and quality have helped fuel more customer demand.”
As inventory for chip designers remains lower this quarter than the typical seasonal level, “we expect that our demand will continue to be strong and above seasonal [norms] in all major regions,” Liu said.
Liu said the company would also see positive sequential growth in the third and fourth quarters, but the growth would “be normal and be more moderate than the second quarter,” as customers’ inventory would return to seasonal levels in the middle of this year, he said.
TSMC said it is to ship a high volume of 20-nanometer chips in the second half of this year and start mass production of next-generation 16-nanometer chips next year as scheduled.
The company expects the global semiconductor industry to see revenue grow by 7 percent annually this year, compared with a 5 percent increase estimated three months ago, and chip designers would see revenue rise by 9 percent annually from 8 percent previously forecast, Liu said.
The chip foundry industry would expand revenue by 14 percent this year, up from an earlier 10 percent prediction, Liu said. TSMC’s revenue growth this year would outpace the rest of the industry by several percentage points, he said.
During the quarter ending March 31, TSMC’s net profit expanded 6.8 percent to NT$47.87 billion, or NT1.85 per share, compared with NT$44.81 billion, or NT$1.73 per share, in the fourth quarter of last year. On an annual basis, the figure represented a growth of 21 percent.
Gross margin improved to 47.5 percent last quarter from 44.5 percent in the fourth quarter of last year, while operating profit margin rose to 35.4 percent from 32.8 percent.
This quarter, TSMC expects gross margin to climb to between 47.5 percent and 49.9 percent, while operating profit will rise to between 36.5 percent and 38.5 percent.
Liu said revenue contribution from high-end smartphones would rise to US$14 per unit this year, from US$10.8 last year.
NOTABLE SHIFT: By 2030, 50% of all laptops would be assembled in Southeast Asia, while Taiwan would still mostly focus on research and development, a report said Global laptop and desktop computer supply chains are expected to shift significantly away from China in the next 10 years, a Market Intelligence & Consulting Institute (MIC, 產業情報研究所) report said. By 2030, only 40 percent of global laptop production would remain in China, said the report, which was released on Thursday. “The reshuffling of the global supply chain will be one of the most important trends in the next 10 years,” the institute said in the report. “In the long run, key component makers will follow laptop assemblers in moving out of China.” The Taipei-based institute predicted most key component makers
Yageo Corp (國巨), the world’s third-largest supplier of multilayer ceramic capacitors, has formed a strategic alliance with Hon Hai Precision Industry Co (鴻海精密) to develop key electronic components for electric vehicles and digital healthcare, it said yesterday. The alliance is to help Yageo boost its revenue from high-end components for vehicles and industrial, medical and aerospace devices, as well as those used in 5G and Internet-of-Things devices, the company said. The companies signed the strategic alliance agreement at Yageo’s headquarters in New Taipei City’s Sindian District (新店). Their cooperation is to start this quarter, the companies said in a joint statement. “Through the cooperation
SUPPLY CONSTRAINTS: The transferred orders might not provide an immediate revenue boost given local chipmakers’ high utilization rates, a senior analyst said Shares of local contract chipmakers yesterday rose as much as the 10 percent daily limit, as investors bet on orders being transferred from Semiconductor Manufacturing International Corp (SMIC, 中芯國際) after the US imposed export restrictions on the Chinese chipmaker. United Microelectronics Corp (UMC, 聯電) shares soared 10 percent to close at NT$27.5 as 380 million shares changed hands on the Taiwan Stock Exchange. UMC is the world’s No. 3 foundry by revenue, followed by SMIC, according to data from market researcher TrendForce Corp (集邦科技). UMC has product and customer portfolios similar to those of SMIC, TrendForce said, adding that UMC offers 14-nanometer and
‘IMPORTANT MILESTONE’: The firm expects to launch the generic of Revlimid in the US after March 2022. It has already launched the product in some European countries Lotus Pharmaceutical Co Ltd (美時化學製藥) has received tentative approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lenalidomide, the company said in a statement on Friday. The ANDA approval is for 2.5mg, 5mg, 10mg, 20mg and 25mg capsules of lenalidomide, which is a generic version of blood cancer drug Revlimid developed by Celgene Corp. It is the first product fully developed and manufactured in Lotus’ facilities in Taiwan. Lotus expects to launch the product in the US — based on its patent litigation settlement with Celgene last year — some time after March